Loading…
Loading…
SAN CLEMENTE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2026 earnings release and conference call.
Beta Bionics (NASDAQ: BBNX - Get Free Report) and ICU Medical (NASDAQ: ICUI - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk. Risk and Volatility Beta Bionics has a beta
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
ICU Medical, Inc. (NASDAQ: ICUI - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine analysts that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and two have given a strong buy rating to
On September 22, 2026, ICU Medical Inc (ICUI) shares rose 3.7%, bringing the current price to $160.98. The stock has fluctuated within a 52-week range of $112.5
Ambu A/S (OTCMKTS:AMBBY - Get Free Report) and ICU Medical (NASDAQ: ICUI - Get Free Report) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends. Earnings and Valuation This table compares Ambu
The sale was part of a trading plan established in June.
Jushi (OTCMKTS:JUSHF - Get Free Report) and ICU Medical (NASDAQ: ICUI - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends. Risk and Volatility Jushi has a beta of -0.63,